SCHEMBL6606883

SCHEMBL6606883

Cc1nc(-c2ccccc2)sc1C(=O)Nc1cccc(OCCN(C(C)C)C(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.51
MCHR1 Q99705 6/20 0.51
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
POLB P06746 2/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 1/20 0.50
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MAPT P10636 2/20 0.49
GAA P10253 1/20 0.49
NR1H4 Q96RI1 1/20 0.49
HPGD P15428 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
DGAT1 O75907 1/20 0.47
HTR2C P28335 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604450 0.93 ROCK1 (0.54) PARP1MCHR1MEN1KMT2APOLB
SCHEMBL6602401 0.92 MAPT (0.51) PARP1MCHR1MEN1KMT2APOLB
SCHEMBL6607020 0.90 NR1H4 (0.62) MCHR1MEN1KMT2APOLBNPC1
SCHEMBL6603223 0.89 KMT2A (0.58) PARP1MCHR1MEN1KMT2APOLB
SCHEMBL6606889 0.87 PARP1 (0.51) PARP1MEN1KMT2APOLBNPC1
SCHEMBL6602805 0.85 MCHR1 (0.62) MCHR1MEN1KMT2APOLBHTR2C
SCHEMBL6604027 0.83 MAPT (0.58) MCHR1MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL6604459 0.80 MAPT (0.52) PARP1MEN1KMT2APOLBNPC1
SCHEMBL6602409 0.80 MAPT (0.51) PARP1MEN1KMT2APOLBNPC1
SCHEMBL6925375 0.80 MCHR1 (0.78) MCHR1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102535-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2004-09-29 EP disclosed
US-6399656-B1 USING A BENZOPYRAN-3-CARBOXAMIDE COMPOUND SMITHKLINE BEECHAM CORPORATION 2002-06-04 US disclosed
EP-1102535-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2001-05-30 EP disclosed
WO-2000006085-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-10 WO disclosed